Feasibility of MASK-air® use in allergic rhinitis patients receiving immunotherapy and the effect on quality of life
MASK-air<sup>®</sup> serves as a valuable tool for physicians in managing treatment and is associated with validated, reliable scales. Its use was linked to enhanced QoL and symptom reduction among participants, irrespective of treatment duration.
Authors
- Arzu Yorgancıoğlu (ORCID: https://orcid.org/0000-0002-4032-0944)
- Cengiz Kırmaz (ORCID: https://orcid.org/0000-0001-8873-1681)
- Özge KAMA BAŞCI (ORCID: https://orcid.org/0000-0002-2755-6768)
- Soner Gunes
Institutions
- Balıkesir University (TR)
- Manisa Celal Bayar University (TR)
- Pamukkale University (TR)
Publication Details
- Journal
- Allergologia et Immunopathologia
- Published
- 2025-05-01
- DOI
- https://doi.org/10.15586/aei.v53i3.1208
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00